Company
Headquarters: Surrey, BC, Canada
CEO: Dr. John McGraw M.Sc., Ph.D.
C$7.4 Million
CAD as of Jan. 1, 2024
US$5.6 Million
Company | Market Cap (USD) |
---|---|
Thermo Fisher Scientific | $207.62 B |
Danaher | $171.89 B |
Siemens Healthineers AG | $66.05 B |
DexCom, Inc. | $46.50 B |
IDEXX Laboratories, Inc. | $44.72 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes breast CT Imaging system; and next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Izotropic Corp has the following listings and related stock indices.
Stock: CSE: IZO wb_incandescent
Stock: FSX: 1R3 wb_incandescent
Stock: OTC: IZOZF wb_incandescent